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Abstract
Background: Humans and animals show a certain consistency in the response of their serum lipids
to fat-modified diets. This may indicate a genetic basis underlying this response. Coffee oil might be
used as a model substance to investigate which genes determine differences in the serum lipid
response. Before carrying out such studies our objective was to investigate to what extent the
effect of coffee oil on serum lipid concentrations is reproducible within subjects.
Methods: The serum lipid response of 32 healthy volunteers was measured twice in separate five-
week periods in which coffee oil was administered (69 mg cafestol / day).
Results: Total cholesterol levels increased by 24% in period 1 (range:0;52%) and 18% in period 2
(1;48%), LDL cholesterol by 29 % (-9;71%) and 20% (-12;57%), triglycerides by 66% (16;175%) and
58% (-13;202%), and HDL cholesterol did not change significantly: The range of the HDL response
was -19;25% in period 1 and -20;33% in period 2.
The correlation between the two responses was 0.20 (95%CI -0.16, 0.51) for total cholesterol, 0.16
(95%CI -0.20, 0.48) for LDL, 0.67 (95%CI 0.42, 0.83) for HDL, and 0.77 (95%CI 0.56, 0.88) for
triglycerides.
Conclusions: The responses of total and LDL cholesterol to coffee oil were poorly reproducible
within subjects. The responses of HDL and triglycerides, however, appeared to be highly
reproducible. Therefore, investigating the genetic sources of the variation in the serum-lipid
response to coffee oil is more promising for HDL and triglycerides.
Background
The effect of dietary changes on serum lipid levels differs
significantly between individuals [1–5]. The differences in
response may be caused by variation in genes regulating
serum lipid levels [6–8]. Identification of genes regulating
the lipid response may help to clarify the mechanism by
which diet raises serum lipid levels. It also might provide
leads for dietary and pharmacotherapeutical means of
lowering serum cholesterol. Cafestol, a cholesterol-raising
substance in coffee oil, can be used to study lipid
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metabolism and the genes involved [9–11] because it
greatly affects serum lipid levels in humans [9–11]. There-
fore, coffee oil can be used to affect serum lipid levels
without the need to provide a fully controlled diet. The
effect of coffee oil on the expression of genes in humans,
however, is difficult to study in relevant tissues like liver
or intestinal epithelium.
An alternative approach is to study the response of serum
lipids to coffee oil in individuals having different geno-
types of certain polymorphic candidate genes. For such an
approach to succeed, two conditions must be met: First,
the response of lipids to coffee oil should be sufficiently
different between persons; if this is not the case, the effect
of the candidate polymorphisms on the response may be
too small to be detected in a study. Second, the individual
response of lipids to coffee oil should be sufficiently
reproducible; otherwise an efficient study of the effects of
genetic factors may not be possible. If these two condi-
tions are not met, the study of individual polymorphisms
is not feasible.
The present study was therefore designed to assess the
reproducibility and the reliability of the response to coffee
oil in subjects from the general population.
Methods
Subjects
Subjects were recruited among the student population of
Wageningen, a university town in the Netherlands.
Fifty-one men and women were recruited; their health was
assessed by means of a questionnaire, and blood and
urine testing. We used the following eligibility criteria:
serum cholesterol < 8 mmol/l, serum triglycerides < 3.0
mmol/l, no glucosuria, normal liver enzyme activities in
serum, no use of medication with effects on serum lipids,
and no history of gastrointestinal or liver disease. Because
coffee oil can increase the activities of the liver enzymes
alanine aminotransferase (ALAT) and aspartate ami-
notransferase (ASAT) [9,12]. We measured liver enzyme
activities before and during the study. One subject was
excluded at baseline because of liver enzyme activity
above the upper limit. Consequently, fifty subjects were
enrolled in the study.
During the study five subjects withdrew cooperation:
three subjects suffered from stomach complaints, one
went abroad, and one had a gastrointestinal infection.
Another 13 subjects had to be excluded during the study
because their serum activities of ALAT and ASAT exceeded
previously determined boundaries. These boundaries
were 2.7 times the upper limit of normal for ALAT and 1.5
times the upper limit of normal for ASAT.
Thus, thirty-two subjects completed the study. The Medi-
cal Ethical Committee of Wageningen University and
Research Centre approved the study. Each volunteer gave
an informed consent.
Study design
The response of serum lipids to coffee oil consumption
was measured twice in each subject.
Subjects first entered a run-in period of three weeks in
which they received four placebo capsules daily. Placebo
capsules contained 0.25 ml sunflower oil and 0.25 ml saf-
flower oil per capsule.
After the run-in period subjects took four coffee-oil cap-
sules a day (2 ml oil per day) for a five-week period. The
coffee-oil capsules provided 69 mg cafestol and 51 mg of
kahweol per day. The run-in and the coffee-oil period
together constituted period 1. The change in the level of
serum lipids from the end of run-in period 1 to the end of
coffee-oil period 1 was defined as response 1. This first
coffee-oil period was followed by a three-week wash-out
period in which no capsules were supplied.
After the wash-out period subjects repeated the first two
periods: a three-week run-in period (run-in 2) and a five-
week coffee-oil period (coffee-oil period 2). See figure 1
for a diagram of the study design.
Subjects were asked to maintain their lifestyles and dietary
habits for the duration of the study. They reported
changes in diet, smoking, physical activity, use of medica-
tion, illness, and the number of capsules taken daily in
diaries.
We measured body weight at the beginning of the run-in
and coffee-oil periods and at the end of the coffee-oil
periods.
Blood lipids
Blood samples were taken from subjects who had fasted
overnight on four separate days in the last two weeks of
the run-in and coffee-oil periods. In total, each subject
had blood drawn 19 times. In 16 samples serum lipid lev-
els were determined. All 16 samples were analysed within
one run. Total cholesterol and triglycerides were measured
with Cholesterol Flex and Triglycerides Flex reagent car-
tridge (Dade Behring); HDL was measured with the Liquid
N-geneous HDL assay (Instruchemie BV.); LDL choles-
terol concentrations were calculated [13].
Liver enzymes
To measure liver enzyme activities, we took additional
blood samples during the second week of the two coffee-
oil periods and within two months after the experiment.Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/8
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In these samples activities of ALAT (Alanine Aminotrans-
ferase Flex reagent cartridge, Dade Behring) and ASAT
(Aspartate Aminotransferase Flex reagent cartridge, Dade
Behring) were measured at 37°C. Liver enzyme activities
are given in multiples of the upper limit of normal
because activities vary with the temperature used when
determining liver enzyme activities in different laborato-
ries. The upper limits of normal in this laboratory are 45
IU/l for ALAT and 41 IU/l for ASAT. When ALAT levels
exceeded the 2.7 times upper limit of normal or ASAT lev-
els exceeded 1.5 times upper limit of normal, subjects
were taken off coffee-oil treatment. These boundaries
were based on what is considered a mild increase in liver
enzymes activities in plasma [9,12].
Statistical analysis
A subject's response to coffee-oil in period 1 was defined
as the mean serum lipid level at the end of coffee-oil
period 1 minus the mean at the end of run-in period 1.
The mean level of serum lipids in a period is calculated as
the mean of the four repeated measurements in each
period. The response in period 2 was calculated in the
same way.
We calculated within and between person standard devia-
tions (SD's) of serum lipid levels in the four periods and
the two responses. The four periods are: run-in 1, run-in
2, coffee-oil 1 and coffee-oil 2.
We used the following definitions in our calculations:
SDtotal of run-in 1: SD of the mean serum lipid level of 32
subjects in run-in 1.
SDtotal response: SD of the mean serum lipid response of
32 subjects. The mean response is calculated from the two
responses.
SDwithin level of person1 in run-in 1: SD of the four meas-
urements in run-in 1 of person 1.
SDwithin response of person 1: SD of the two responses for
person 1.
SDbetween : √(SDtotal2 - SDwithin2)
Results
We analysed data of 32 subjects, 10 men and 22 women.
See table 1 for baseline characteristics. During the study
97% of the total amount of capsules was consumed. This
was determined by counting returned capsules and check-
ing diaries.
Body weight
There was an average weight change of -0.4 kg (range: -3.8
to + 3.8, n = 32) from start to end of the experiment. There
was no correlation between changes in weight and the
response of serum lipids (data not shown).
Blood lipids
Table 2 shows the mean responses of serum lipids to cof-
fee oil in periods 1 and 2. Total cholesterol rose by 24%
(range:0;52%) in period 1 and by 18% (1;48%) in period
2, LDL cholesterol by 29% (-9;71%) and 20% (-12;57%),
triglycerides by 66% (16;175%) and 58% (-13;202%) and
HDL cholesterol rose by 3% in both periods. These
changes in HDL levels were not significant. The ranges of
Diagram of the study design Figure 1
Diagram of the study design. The week number is indicated above. Black arrows indicate blood sampling days. Dashed 
arrows indicate blood sampling days for determination of liver enzyme activities.Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/8
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the HDL response were -19;25% in period 1 and -20;33%
in period 2.
Individual responses for total and LDL cholesterol in
period 2 hardly correlated with those in period 1. In con-
trast, individual responses in the two periods for HDL
cholesterol (fig. 2) and triglycerides (fig. 3) were highly
correlated: the Pearson correlation coefficient was 0.67 for
HDL and 0.77 for triglycerides. See table 2 for mean levels
and responses.
The total observed standard deviation of the response
(SDtotalresponse) of serum cholesterol to coffee oil was
0.49 mmol/l. The between subject standard deviation
(SDbetween) of the response of serum cholesterol was 0.22
mmol/l and the within subject standard deviation
(SDwithin response) was 0.44 mmol/l. Therefore, a large
proportion of the variation in serum cholesterol response
to coffee oil was explained by the variation in the response
within individuals. The same is true for the LDL response.
The HDL response to coffee oil showed a between subject
SD of 0.15 and a within subject SD of 0.11 mmol/l, so the
between subject variation was larger than the within sub-
ject variation. This explains the high correlation between
the two HDL responses.
The triglyceride response showed an SD between individ-
uals of 0.40 mmol/l, which is larger than the within sub-
ject SD of 0.22 mmol/l. All standard deviations of serum
lipid levels and responses to coffee-oil are presented in
Table 3.
Multiple regression analysis showed no association
between the response and gender, baseline values, or alco-
hol use. Only smoking status contributed significantly to
the explanation of the variation of the response. However,
we did not find a difference in the reproducibility of the
serum lipid response to coffee oil between smokers and
non-smokers (data not shown).
Liver enzymes
Eight subjects dropped out in the first period and five in
the second period because of ALAT and ASAT levels
exceeding the predetermined boundaries. Eleven of these
13 subjects had returned to normal ALAT (≤ 45 IU/l) and
Table 1: Baseline characteristics for all subjects who completed the study
Characteristic (n = 32)
Age (years) 23 ± 4
Height (m) 1.73 ± 0.09
Weight (kg) 67.4 ± 10.4
Body mass index (kg/m2) 22.4 ± 3.0
Serum total cholesterol (mmol/l) 4.6 ± 0.8
Serum triglycerides (mmol/l) 1.00 ± 0.49
Alanine aminotransferase (IU/l) 25 ± 7
Aspartate aminotransferase (IU/l) 14 ± 4
Current smokers n (%) 7 (22)
Alcohol (glass/week) median (25th percentile, 75th percentile) 3 (1, 7)
Variables presented as mean ± sd, current smokers presented as n (%).
Table 2: Concentrations of blood lipids during the four study periods
Total cholesterol HDL LDL Triglycerides
Run-in 1 (mmol/l) 4.4 ± 0.7 1.56 ± 0.34 2.39 ± 0.57 1.10 ± 0.38
Coffee oil 1 (mmol/l) 5.5 ± 0.9 1.61 ± 0.44 3.08 ± 0.77 1.82 ± 0.62
Run-in 2 (mmol/l) 4.5 ± 0.8 1.55 ± 0.45 2.41 ± 0.66 1.12 ± 0.47
Coffee oil 2 (mmol/l) 5.3 ± 0.8 1.60 ± 0.45 2.90 ± 0.69 1.77 ± 0.76
Response 1 (mmol/l) 1.1 ± 0.5 0.04 ± 0.18 0.70 ± 0.40 0.72 ± 0.40
Response 2 (mmol/l) 0.8 ± 0.5 0.05 ± 0.20 0.49 ± 0.44 0.65 ± 0.52
Correlation between response 1 and 2 0.20 [-0.16, 0.51] 0.67 [0.42, 0.83] 0.16 [-0.20, 0.48] 0.77 [0.56, 0.88]
Values are mean ± SD The values for each period are means of four samples. Response1 and response2 are calculated as coffee-oil minus run-in 
values. Values between brackets are 95% confidence intervalsNutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/8
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ASAT (≤ 41 IU/l) levels within two months after exclusion.
One subject who had elevated liver enzyme activities after
two months was referred to a general practitioner. After
another two months her liver enzyme levels were within
normal limits again. One subject went abroad before the
follow-up measurement.
The ALAT levels of the 32 subjects who finished the study
rose on average by 0.51 ± 0.47 times the upper limit of
normal during the first coffee-oil period and by 0.31 ±
0.29 times the upper limit of normal during the second
period. ASAT levels increased by 0.22 ± 0.20 times the
upper limit of normal during the first period and by 0.15
± 0.12 times the upper limit of normal during the second
period.
Discussion
In this study we aimed to establish the reproducibility of
the serum-lipid response to coffee oil. We found that the
response of total serum cholesterol and LDL to coffee oil
was poorly reproducible, whereas the responses of HDL
and triglycerides to coffee oil proved to be highly repro-
ducible. A high correlation between two intra-individual
responses means that the within-subject variability is rel-
atively low. The between-subject variability of HDL and
triglycerides is relatively large. The within-subject
reproducibility of the responses of HDL and triglycerides
to coffee oil in combination with their large between-sub-
ject variability indicates that it is more promising to inves-
tigate genetic variation that determines the response of
HDL and triglycerides to coffee oil than to investigate the
responses of total and LDL cholesterol.
The triglyceride response is relatively large compared to
the response of total cholesterol. In our study cholesterol
increased on average by 21 % and triglycerides by 62%. It
has been shown that cafestol increases plasma triglycer-
ides by an increasing production of a fraction of very low
density lipoproteins: VLDL1. The subsequent rise in LDL
cholesterol might be caused by enrichement of VLDL2 par-
ticles with cholesteryl esters [14].
Group vs. individual response of serum lipids
The average response to the coffee-oil treatment was sim-
ilar to that in previous studies at our department [11]. We
expected an increase in total serum cholesterol of 1.0
mmol/l and an increase of serum triglycerides of 0.65
mmol/l, which is close to the observed values (Table 2).
The coffee oil did not affect the average HDL concentra-
tion. Other studies also found either no effect on HDL or
a slight decrease in HDL concentrations [11].
The assessment of the individual response of serum lipids
is hampered by day-to-day fluctuations in serum lipid lev-
els [3–5]. In this experiment we reduced the effect of these
Correlation of HDL response to coffee-oil consumption  between period 1 and 2 Figure 2
Correlation of HDL response to coffee-oil consump-
tion between period 1 and 2. On the x-axis the response 
of coffee-oil in the first period on serum HDL is shown on 
the y-axis the response to coffee-oil in the second period. 
Each dot represents one subject.
Correlation of triglyceride response to coffee-oil consump- tion between period 1 and 2 Figure 3
Correlation of triglyceride response to coffee-oil con-
sumption between period 1 and 2. On the x-axis the 
response of coffee-oil in the first period on serum triglycer-
ides is shown on the y-axis the response to coffee-oil in the 
second period. Each dot represents one subject.Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/8
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fluctuations by using the mean of four separate measure-
ments [15,16].
Analyses of the between and within-person standard devi-
ations (SD's) of the responses of serum lipids to coffee oil
confirm that total cholesterol and LDL responses are
poorly reproducible. The SD's of the responses of total
cholesterol and LDL had a within-person component that
was clearly larger than the between-person component.
For the total cholesterol response to coffee oil we found a
total SD of 0.49 mmol/l, an SDwithin of 0.44 mmol/l, and
an SDbetween of 0.22 mmol/l. This is at variance with the
results of Katan et al who observed an SD of 0.33 mmol/l,
an SDwithin of 0.16 mmol/l, and an SDbetween  of 0.29
mmol/l for total cholesterol [2]. This would indicate a bet-
ter reproducibility than observed in our study. However,
Katan et al selected putative hyperresponders and hypore-
sponders which will lead to overestimation of the repro-
ducibility. In our study the response of triglycerides shows
a large SD between individuals and a quite small SD
within persons. This confirms that the response varies
between individuals and that the response is reproducible
within persons.
We did not separate laboratory variation in our model for
calculation of SD's. We estimated this variation by meas-
uring serum lipids in 32 duplo samples. Coefficients of
variation were 1.6% for total cholesterol, 1.8% for HDL,
and 2.3% for triglycerides. This means that the laboratory
variation is so small that it can be omitted from the model
without affecting the calculated values of SDwithin and
SDbetween.
Study limitations
Although cafestol is a potent cholesterol-raising food
component, it is not certain that it can be used for the
study of variation in genes regulating the serum-lipid
response to other foods. It is possible that cafestol regu-
lates different genes than other food components such as
dietary cholesterol or saturated fats do. Furthermore, we
did not use pure cafestol in this study, but coffee oil,
which contains many more components, such as triglycer-
ides, free fatty acids, and sterols. However, coffee-oil
stripped of diterpenes has no effect on serum lipids [9].
Therefore, genes that cause a rise in serum cholesterol are
probably affected by diterpenes.
Table 3: Standard deviations of levels and responses to cafestol of serum lipids
Mean (mmol/l) Sdtotal Sdwithin Sdbetween
Total cholesterol
Run-in 1 4.45 0.72 0.26 0.67
Coffee-oil 1 5.51 0.93 0.37 0.85
Run-in 2 4.47 0.79 0.26 0.75
Coffee-oil 2 5.30 0.85 0.33 0.78
Response 0.95 0.49 0.44 0.22
HDL
Run-in 1 1.56 0.34 0.10 0.32
Coffee-oil 1 1.61 0.44 0.12 0.42
Run-in 2 1.55 0.34 0.10 0.32
Coffee-oil 2 1.60 0.45 0.10 0.44
Response 0.05 0.19 0.11 0.15
LDL
Run-in 1 2.39 0.57 0.23 0.52
Coffee-oil 1 3.08 0.77 0.34 0.69
Run-in 2 2.41 0.66 0.21 0.63
Coffee-oil 2 2.90 0.69 0.33 0.61
Response 0.60 0.42 0.39 0.16
Triglycerides
Run-in 1 1.10 0.38 0.23 0.30
Coffee-oil 1 1.82 0.62 0.39 0.48
Run-in 2 1.12 0.47 0.22 0.42
Coffee-oil 2 1.77 0.76 0.42 0.63
Response 0.69 0.46 0.22 0.40Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/8
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Another limitation of the study is that the subjects were
free living and did not receive a controlled diet. Therefore,
the response of serum lipids to the coffee oil could be
changed by other factors. We instructed the subjects to
maintain dietary habits, smoking habits, and physical
activity. Changes were recorded in a diary together with
use of medication and illness. According to the diaries,
subjects maintained their habitual lifestyle. Furthermore,
coffee oil has such a large effect on serum-lipid levels that
small effects of other factors are not of great concern.
A fourth limitation is the large drop out due to elevations
of liver enzymes. There was, however, no correlation
between the rise in serum-lipid levels and the rise in liver
enzymes (data not shown). Therefore, there is no reason
to assume that the reproducibility of the serum lipid
response to coffee oil in subjects who showed a
considerable increase of liver enzymes differs from the
serum lipid response in subjects who did not show a large
increase of liver enzymes.
On basis of this study it can not be concluded with cer-
tainty that a response to coffee oil that differs between
individuals but is reproducible within individuals is deter-
mined by genetic variation.
Liver enzymes
Levels of the liver enzymes ALAT and ASAT rose after
administrating coffee oil, as was expected from previous
studies [9,11,12,17]. The rises in ALAT and ASAT indicate
that coffee oil can cause acute injury to hepatocytes
[18,19]. Alcohol, being hepatotoxic, might be an impor-
tant cofactor in this effect [20]. In this study no associa-
tion between use of alcohol and drop out due to elevation
of liver enzymes was observed. Levels of ALAT rose more
than ASAT levels did. This could mean that the mem-
branes of hepatocytes were damaged [18,20].
Genetic factors underlying the serum lipid response to 
cafestol
Given the ratio of between and within person variability
of the responses of HDL and triglycerides to coffee oil,
research into genetic determinants of the response seems
to be feasible.
Other studies have described polymorphisms in genes
that have a small effect on the total-cholesterol response
to cafestol and dietary fat [6–8]. An example is the choles-
teryl ester transfer protein (CETP). CETP is a protein that
mediates the transfer of cholesteryl esters from HDL to
LDL and VLDL. Cafestol, like dietary cholesterol and fat,
might increase the transfer of cholesteryl esters by increas-
ing the activity of CETP. Weggemans et al. showed that
humans with the CETP Taqlb-1/2 allele have a smaller
response of LDL to cafestol, or dietary fat and cholesterol
[21]. However, it remains to be established whether CETP
has a role in the cholesterol-raising effect of cafestol and
whether a polymorphism in the gene accounts for some of
the variation in response between individuals.
Other candidate genes are genes encoding for proteins in
the bile acid metabolism. Cholesterol is converted to bile
acids in the liver. There are two pathways involved: the
neutral and the acidic pathway. The rate-limiting enzyme
in the neutral pathway is 7α-hydroxylase, which is regu-
lated by bile acids through a negative feedback mecha-
nism [22]. Chenodeoxycholic acid (CDCA), a primary
bile acid, suppresses 7α-hydroxylase activity by binding
directly to the farnesoid X receptor [23,24]. It has been
shown in mice that cafestol inhibits bile acid synthesis,
which could cause the rise in serum cholesterol [25]. If
functional polymorphisms are present in the genes
involved in bile acid metabolism, these could be respon-
sible for the variation in the conversion of cholesterol to
bile acids. Therefore, it is interesting to study whether caf-
estol regulates genes involved in bile-acid metabolism.
Polymorphisms in the genes of the pathways mentioned
above could account for the variation in response to caf-
estol between individuals. There are more possible candi-
dates, such as sterol regulatory element binding proteins,
microsomal triglyceride transfer protein, lecithin:choles-
terol acyltransferase, lipoprotein lipase, and hepatic
lipase.
In this study the responses of HDL and triglycerides to cof-
fee oil showed a sufficient reproducibility. Therefore, our
best option is to focus on these serum lipids and charac-
terize an individual's response to coffee oil by the HDL
and triglyceride response in future research. The variation
between persons in the response of HDL and triglycerides
combined with the consistency within persons does not
guarantee that a large genetic effect is present. It means
that environmental determinants of the response were
stable within individuals during the time span of the
study, whereas there were differences between individuals
in other environmental determinants and/or genetic
determinants. The question remains whether possible
genetic effects are large enough to be detected and
whether variation in these genes is sufficiently prevalent
in the population.
Clarification of the mechanism by which cafestol
increases serum lipids might provide leads for dietary and
pharmacotherapeutical ways to lower serum cholesterol.
The 'cafestol model' also could be a trial case for evaluat-
ing the possibility of personalized diets. If it is possible to
predict people's serum-lipid responses to cafestol on basis
of their genetic make-up and to make dietaryPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Nutrition Journal 2003, 2 http://www.nutritionj.com/content/2/1/8
Page 8 of 8
(page number not for citation purposes)
recommendations based on this genetic information, this
could also be applicable in other situations.
Author's contributions
MVB participated in designing and planning the study,
headed the investigation during the intervention period,
analysed the data and wrote the paper together with MFE,
who also contributed to the data analysis. MBK initiated
the project and raised the funds. EGS was the senior scien-
tist supervising the project.
Acknowledgements
This study was sponsored by the Dutch organisation of scientific research 
(NWO) and the Wageningen Centre for Food Sciences (WCFS). We are 
indebted to the volunteers who participated in this study. We also like to 
thank Dr M Blanc of Nestlé for providing the coffee oil. Furthermore we 
would like to thank all the dieticians, laboratory personnel and students 
involved in this project.
References
1. Beynen AC and Katan MB: Reproducibility of the variations
between humans in the response of serum cholesterol to
cessation of egg consumption. Atherosclerosis 1985, 57(1):19-31.
2. Katan MB, Beynen AC, De Vries JH and Nobels A: Existence of con-
sistent hypo- and hyperresponders to dietary cholesterol in
man. Am J Epidemiol 1986, 123(2):221-34.
3. Katan MB and Beynen AC: Characteristics of human hypo- and
hyperresponders to dietary cholesterol. Am J Epidemiol 1987,
125(3):387-99.
4. Beynen AC, Katan MB and Van Zutphen LF: Hypo- and hyperre-
sponders: individual differences in the response of serum
cholesterol concentrations to changes in diet. Adv Lipid Res
1987, 22:115-71.
5. Katan MB, Van Gastel AC, De Rover CM, Van Montfort MA and Knu-
iman JT: Differences in individual responsiveness of serum
cholesterol to fat-modified diets in man. Eur J Clin Invest 1988,
18(6):644-7.
6. Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jimenez F, Lichtenstein
AH and Schaefer EJ: Gene-diet interactions in determining
plasma lipid response to dietary intervention. Atherosclerosis
1995, Suppl 118:S11-S27.
7. Ordovas JM and Schaefer EJ: Genes, variation of cholesterol and
fat intake and serum lipids. Curr Opin Lipidol 1999, 10:15-22.
8. Clifton PM and Abbey M: Genetic control of response to dietary
fat and cholesterol. World Rev Nutr Diet 1997, 80:1-14.
9. Weusten-van der Wouw MP, Katan MB, Viani R, Huggett AC, Liardon
R and Liardon R: Identity of the cholesterol-raising factor from
boiled coffee and its effects on liver function enzymes. J Lipid
Res 1994, 35:721-33.
10. Urgert R, Van der Weg G, Kosmeijer-Schuil TG, Van den Bovenkamp
P and Hovenier R: Levels of the cholesterol-elevating diterpe-
nes cafestol and kahweol in various coffee brews. J Agric Food
Chem 1995, 43:2167-72.
11. Urgert R and Katan MB: The cholesterol-raising factor from cof-
fee beans. Annu Rev Nutr 1997, 17:305-24.
12. Urgert R, Essed N, Van der Weg G, Kosmeijer-Schuil TG and Katan
MB: Separate effects of the coffee diterpenes cafestol and
kahweol on serum lipids and liver aminotransferases. Am J Clin
Nutr 1997, 65(2):519-24.
13. Friedewald WT, Levy RI and Fredrickson DS: Estimation of the
concentration of low-density lipoprotein cholesterol in
plasma, without use of the preparative ultracentrifuge. Clin
Chem 1972, 18(6):499-502.
14. de Roos B, Caslake MJ, Stalenhoef AF, Bedford D, Demacker PN,
Katan MB and Packard CJ: The coffee diterpene cafestol
increases plasma triacylglycerol by increasing the produc-
tion rate of large VLDL apolipoprotein B in healthy normol-
ipidemic subjects. Am J Clin Nutr 2001, 73(1):45-52.
15. Cooper GR, Myers GL, Smith SJ and Sampson EJ: Standardization
of lipid, lipoprotein and apolipoprotein measurements. Clin
Chem 1988, 34(8B):B95-105.
16. Cooper GR, Myers GL, Smith SJ and Schlant RC: Blood lipid meas-
urements: Variations and practical utility.  JAMA 1992,
267(12):1652-60.
17. Urgert R, Schulz AG and Katan MB: Effects of cafestol and kah-
weol from coffee grounds on serum lipids and serum liver
enzymes in humans. Am J Clin Nutr 1995, 61(1):149-54.
18. Keil R: Determination of enzyme activities in serum for the
detection of xenobiotic effects on the liver. Exp Pathol 1990,
39:157-64.
19. Herrera JL: Abnormal liver enzyme levels. The spectrum of
causes. Postgrad Med 1993, 93(2):113-6.
20. Sherman KE: Alanine amintransferase in clinical practice. A
review. Arch Intern Med 1991, 151(2):260-5.
21. Weggemans RM, Zock PL, Ordovas JM, Ramos-Galluzi J and Katan
MB: Genetic polymorphisms and lipid response to dietary
changes in humans. Eur J Clin Invest 2001, 31(11):950-957.
22. Princen HM, Post SM and Twisk J: Regulation of bile acid
synthesis. Curr Pharmaceut Design 1997, 3(1):59-84.
23. Tu H, Okamoto AY and Shan B: FXR, a bile acid receptor and
biological sensor. Trends Cardiovasc Med 2000, 10(1):30-5.
24. Chawla A, Repa JJ, Evans RM and Mangseldorf DJ: Nuclear recep-
tors and lipid physiology: Opening the X-files. Science 2001,
294(5548):1866-70.
25. Post SM, de Roos B, Vermeulen M, Afman L, Jong MC and Dahlmans
VE: Cafestol increases serum cholesterol levels in apolipo-
protein E*3-Leiden transgenic mice by suppression of bile
acid synthesis. Arterioscler Thromb Vasc Biol 2000, 20(6):1551-6.